MacroGenics, Inc.
Here’s whether MacroGenics, Inc. (MGNX) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.
Positives: trading above the 200-day MA (long-term uptrend intact); 50-day MA is rising (+5.73% over 10 days); strong 1-year return of +107.9%; 3-month momentum positive (+16.0%). Concerns: below the 50-day MA (medium-term momentum negative). Currently 27.2% off its 52-week high. Score: +4/7.
MGNX is holding above its long-term 200-day MA ($2.67) but has slipped below the 50-day MA ($4.31), pointing to short-term weakness in an otherwise intact trend. An RSI of 34.5 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +107.9% compares to +16.5% for SPY (beat the market by 91.4%). The current 27.2% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.